Measurement of Electrical Skin Impedance of Dermal-Visceral Zones as a Diagnostic Tool for Disorders of the Immune System

Abstract

Among complementary medicine approaches, diagnostic screening tools based on neuroreflexology have been recently developed. Such techniques are based on the rationale that measurement of electrical impedance of specific dermal zones might reflect the occurrence of pathological states in the corresponding internal organs or systems. Our objective was to evaluate the reliability of a neuroreflexology-based diagnostic test in diagnosing immune-mediated diseases in a blinded single centre study. Seventy-eight patients with immune-mediated diseases (38 patients with autoimmune diseases (AD), and 40 allergic patients) were included in the study. Thirty age and sex matched healthy subjects were also evaluated as a control group. All the patients and subjects underwent conventional medical history and physical examination. We evaluated a device manufactured by Medex Screen Ltd (Arad, Israel). The Medex Test analysis was carried out by a second physician who was blinded to the previous diagnosis. A high correlation between the formal clinical diagnosis and the results of the measurement of electrical skin impedance was reported, with a specificity of 93.3% and a sensitivity of 81.2%. Both sensitivity and specificity dropped when analysing the autoimmune and the allergic group separately, but remained significant for the autoimmune diseases. Degree of activity of the allergic disorders, or specific treatment, did not affect the diagnostic properties of the described device. The Medex Test neurophysiology based technique has the potential to serve as a diagnostic tool for immune based pathologies. Future studies will define this tool place in routine evaluation and potential screening ability.

Keywords

allergic diseases Medex screen non-conventional medicine skin impedance systemic autoimmune diseases

Get full access to this article

View all access options for this article.

References

American Medical Association . Periodic health examination: a manual for physicians. American Medical Association , 1947.

American Medical Association . Medical evaluations of healthy persons. Council on Scientific Affairs . JAMA 1983; 249: 1626-1633 .

Lawrence RS , Mickalide AD. Preventive services in clinical practice: designing the periodic health examination . JAMA 1987; 257: 2205-2207 .

Zimlichman E , Lahad A , Aron-Maor A , Kanevsky A , Shoenfeld Y. Measurement of electrical skin impedance of derma-visceral zones as a diagnostic tool for inner organ pathologies: a blinded preliminary evaluation of a new technique . IMAJ 2005; 7: 631-634 .

Akeyson EW , Schramm LP. Splanchnic and somatic afferent convergence on cervical spinal neurons of the rat . Am J Physiol 1994; 266: R268-R276 .

Katter JT , Dado RJ , Kostarczyk E , Giesler Jr GJ. Spinothalamic and spinohypothalamic tract neurons in the sacral spinal cord of rats. II. Responses to cutaneous and visceral stimuli . J Neurophysiol 1996; 75: 2606-2628 .

Brown PB , Millecchia R , Lawson JJ , Stephens S , Harton P , Culberson JC. Dorsal horn spatial representation of simple cutaneous stimuli . J Neurophysiol 1998; 79: 983-998 .

Patent number US 10/210, 223. Non-invasive method for internal diseases’ diagnosis.

Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus . Arthritis Rheum 1997; 40: 1725-1725 .

10.

Smolen J , Steiner G. Mixed connective tissue disease: to be or not to be ? Arthritis Rheum 1998; 41: 768-777 .

11.

Vitali C. Classification criteria for Sjogren’s sindrome . Ann Rheum Dis 2003; 62: 94-95 .

12.

Lonzetti LS , Joyal F , Raynauld JP et al. Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma . Arthritis Rheum 2001; 44: 735-736 .

13.

Jennette JC , Falk RJ , Andrassy K et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference . Arthritis Rheum 1994; 37: 187-192 .

14.

Arnett FC , Edworthy SM , Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis . Arthritis Rheum 1988; 31: 315-324 .

15.

Valentine PM. Clinical practice. Allergic rhinitis . N Engl J Med 2005; 353: 1934-1944 .

16.

Global initiative for Asthma . Global strategy for asthma management and prevention. NIH Publication number 02-3659, 2002.

17.

Behrendt H. Atopic eczema and allergy . Curr Allergy Rep 2001; 1: 39-43 .

18.

Nowak-Wegrzyn A , Sampson HA. Adverse reactions to foods . Med Clin North Am 2006; 90: 97-127 .

19.

Solensky R. Drug hypersensitivity . Med Clin North Am 2006; 90: 233-260 .

20.

Eisenberg DM , Davis RB , Ettner SL et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey . JAMA 1998; 280: 1569-1575 .

21.

Hawa M , Beyan H , Leslie RD. Principles of autoantibodies as disease-specific markers . Autoimmunity 2004; 37: 253-256 .

22.

Scofield RH. Autoantibodies as predictors of disease . Lancet 2004; 363: 1544-1546 .

23.

Israeli E , Grotto I , Gilburd B et al. Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease . Gut 2005; 54: 1232-1236 .

24.

Arbuckle MR , McClain MT , Rubertone MV et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus . N Engl J Med 2003; 349: 1526-1533 .

25.

Weetman AP. Autoimmune thyroid disease . Autoimmunity 2004; 37: 337-340 .

26.

Kisand KE , Metskula K , Kisand KV , Kivik T , Gershwin ME , Uibo R. The follow-up of asymptomatic persons with antibodies to pyryvate dehydeogenase in adult population samples . J Gastroenterol 2001; 36: 248-254 .

27.

Nielen MM , van Schaardenburg D , Reesink HW et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis. A study of serial measurements in blood donors . Arthritis and Rheum 2004; 50: 380-386 .

28.

Smeenk RJT , Berden JHM , Swaak AJG. dsDNA autoantibodies. In Peter JB , Shoenfeld Y eds. Autoantibodies. Elsevier , 1996: 227-235.

29.

Shmerling RH , Delbanco TL. The rheumatoid factor: an analysis of clinical utility . Am J Med 1991; 91: 528-534 .